Skip to main content
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. — Investor Relations & Filings

Ticker · SCNI ISIN · US09073Q3039 US Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2023-12-22 Capital/Financing Update
Country US United States of America
Listing US SCNI

About Scinai Immunotherapeutics Ltd.

https://www.scinai.com/

Scinai Immunotherapeutics Ltd. is a clinical-stage biopharmaceutical company operating through two complementary business units. Its internal research and development division focuses on developing innovative biological products for inflammation and immunology (I&I), targeting autoimmune and infectious diseases. The core of its therapeutic pipeline is a platform of Alpaca-derived nanosized antibodies (NanoAbs or VHH-antibodies), developed for conditions such as psoriasis and asthma. The company's second unit, Scinai Bioservices, is a Contract Development and Manufacturing Organization (CDMO). It provides end-to-end services to biotech companies, supporting drug development from early research and process development through to cGMP-compliant manufacturing for clinical trials up to Phase 3.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM F-1
Capital/Financing Update Classification · 100% confidence The document is titled 'AMENDMENT NO. 1 TO FORM F-1' and is filed with the SEC. Form F-1 is a registration statement used by foreign private issuers to register securities under the Securities Act of 1933. The text includes detailed information about the securities offering, selling shareholders, risk factors, and other disclosures typical of a registration statement prospectus. It is not an annual report, earnings release, or any other financial report type. It is also not a simple announcement or certification but a substantive filing related to capital raising and securities registration. Therefore, this document fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities, including registration statements for securities offerings.
2023-12-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains announcements of press releases about scientific publications and preclinical trial results, but does not include detailed financial statements or comprehensive financial data. The document is relatively short (2533 characters) and primarily serves to furnish press releases as exhibits. It does not represent an annual or interim financial report, audit report, or earnings release. It is a regulatory filing providing updates and disclosures as required by the SEC for foreign issuers. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-12-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes an explanatory note about a press release regarding regaining compliance with Nasdaq listing rules. The document is short (2012 characters) and primarily serves to furnish a press release as Exhibit 99.1. There are no detailed financial statements or substantive financial data presented. The document is essentially an announcement of a report (press release) rather than the report itself. According to the MENU VS MEAL RULE, such documents should be classified as Regulatory Filings (RNS).
2023-11-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It discusses compliance with Nasdaq listing rules, financial results for the quarter ended September 30, 2023, changes in financial liabilities, and updates on the company's business strategy and loan maturity extension. The document includes detailed financial and operational updates but is not a full annual or quarterly report. It is a regulatory filing providing material information about the company's status and compliance, typical of a 6-K filing. The document is not a full Annual Report (10-K) or Interim Report (IR) but a periodic regulatory update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-11-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an explanatory note about a press release announcing a non-dilutive grant award. The document is short (2020 characters) and primarily serves to furnish a press release rather than provide detailed financial data or a full report. It does not contain financial statements or substantive financial analysis. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a certification or officer attestation. The document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-11-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes an explanatory note about a press release dated October 31, 2023, regarding the European Investment Bank considering extending the maturity of a financial facility contract. The document is short (2126 characters) and primarily serves to furnish a press release as Exhibit 99.1. There are no detailed financial statements or substantive financial data presented. The document is essentially an announcement of a report (press release) rather than the report itself. According to the 'Menu vs Meal' rule, such a document should be classified as a Regulatory Filing (RNS) because it does not contain the full report or detailed financial data but rather furnishes a press release as an exhibit.
2023-11-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.